Suven Life Sciences’ posts un-audited financial results for the quarter ended September 30, 2012

Read more

Alacris Theranostics enters agreement with GSK

Read more

Pharmexcil spells out clarifications from MoH&FW

Read more

Sun Pharma to acquire DUSA Pharmaceuticals

Read more

Orchid Pharma to exit its Chinese JV

Read more

Indegene to acquire marketing services business assets of Canada-based Aptilon

Read more

US FDA advisory committee approves Novartis’ drug Signifor

Read more

Cipla announces major price reduction on select cancer drugs

Read more

Sun Pharma to acquire DUSA Pharmaceuticals

Read more

Quintiles study confirms validity of data from patients recruited over Internet

Read more